Fidelis Research was founded by professionals with extensive international experience in the medical research field.
Our goal is to become your single point of access for your research and development needs.
Fidelis Research aim is to provide to its customers integrated services from pre-clinical to market authorization stage of product development.
Working on different human tissue procurement projects and clinical trials, Fidelis Research has developed good relations with key opinion leaders in all of our countries of operation. We have a reputation of a trustworthy and professional partner providing flexible, high-quality and client focused human tissue procurement and clinical trial services.
The main advantages Fidelis Research is proud of are:
The team we have
The "can-do" company wide spirit
The region where we do our business
The experienced medical professionals
Repeat business from clients
ISO 9001:2008 standard
The Institute of Virology, Vaccines and Sera “Torlak” is a national institution for prevention, treatment and monitoring of infectious diseases. It was founded by the Government of the Republic of Serbia.
The Institute “Torlak” is one of the oldest institutions of this kind in the world, with more than 80 years of tradition and experience.
The Institute “Torlak” has four national reference laboratories for diagnostics, three of which are certified by the World Health Organization.
The Institute carries out scientific research and educational activities in cooperation with the University of Belgrade.
The Institute “Torlak” is engaged in:
Production of vaccines, sera and other immunobiological and diagnostic preparations
Virological, bacteriological and immunological-allergological diagnostics
Supplying domestic market with the vaccines from the obligatory immunization program
Vaccines storage and distribution - National Vaccine Store Certificate by WHO and UNICEF, 2009
Parexel provides bioequivalence studies as well as clinical services across Phase I to Phase III of drug development including dose escalation, drug-drug interaction, biomarkers, first-in-man studies, ADME, imaging, and clinical research services.
University is an institution which is rightly considered one of the greatest contributions of the peoples of Europe to the world's cultural heritage.
The University of Belgrade is a state university. Its main activities in the fields of higher education and scientific research are activities of public interest, and they are carried out in accordance with the legal regulations.
The University of Belgrade celebrates September 13 as its day. This is the date when lessons started at the first Higher School, founded by Dositej Obradovic.
During the two centuries of its existence the University of Belgrade has served its people, and its former students and teachers have greatly contributed to the development of cultural, scientific, educational, political and economic life of our country.
The University of Belgrade is prepared to maintain and enhance its position as the leading institution of higher education in the region by adapting to the challenges of modern times on one hand, and preserving what's worth in its tradition on the other. This is precisely what makes it recognized as a true national brand.
Nowadays science increasingly tends to overcome the limits imposed by the division into physics, chemistry, biology and other traditional disciplines, by creating teams pursuing a multidisciplinary line of research. Such a concept brings together experts from many areas, enabling them to get a multi-faceted insight into a problem and seek solutions through joint work.
Vinča Institute of Nuclear Sciences is a place where such an approach to research is enabled by its internal organization and established practices. The research at the Institute covers the following areas: physics, chemistry, biology, power engineering and technology, radiation and environmental protection, accelerator science, and materials science.
All of these areas fall within the group of natural and technical sciences. Owing to a multidisciplinary approach, the Institute is capable of responding to the major strategic lines of research defined at the national level: advanced materials and nanoscience, energy engineering and technology, biomedicine and environmental protection.
The total number of employees currently fluctuates around 750, out of which over 250 hold a PhD degree.